Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study

HPV vaccination coverage rates can vary depending on several factors. The main objective of this study is to identify possible independent prognostic factors that have an impact on HPV vaccination in a rural community, specifically related to sexual and reproductive health. A case-control, retrospec...

Descripción completa

Detalles Bibliográficos
Autores: Colomé Ceballos, Lara, Clua Espuny, Josep Lluís, Ceballos García, Concepción, Clua Queralt, Josep, Pla Farnós, Maria Jesús, Fernández Sáez, José
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/204480
Acceso en línea:https://hdl.handle.net/2445/204480
Access Level:acceso abierto
Palabra clave:Vacuna del papil·lomavirus
Cribratge
Papillomavirus vaccines
Medical screening
id ES_b608069d3ceb999af26dd4efcc8dff2e
oai_identifier_str oai:recercat.cat:2445/204480
network_acronym_str ES
network_name_str España
repository_id_str
spelling Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control StudyColomé Ceballos, LaraClua Espuny, Josep LluísCeballos García, ConcepciónClua Queralt, JosepPla Farnós, Maria JesúsFernández Sáez, JoséVacuna del papil·lomavirusCribratgePapillomavirus vaccinesMedical screeningHPV vaccination coverage rates can vary depending on several factors. The main objective of this study is to identify possible independent prognostic factors that have an impact on HPV vaccination in a rural community, specifically related to sexual and reproductive health. A case-control, retrospective, community-based study was carried out on women aged 15 to 40 in the primary health centers of Southern Catalonia's Terres de l'Ebre region, Spain, from 1 January 2020 to 31 December 2022. A random sample of 520 women with an average age of 29.3 (SD 7.8) years old was included in the study. Independent prognostic factors: age OR 0.680 (95% CI: 0.635-0.729, p < 0.001), immigrant origin OR 0.215 (95% CI: 0.109-0.422, p < 0.001), and HPV PCR OR 7.402 (95% CI: 2.504-21.880, p < 0.001). The variables that showed a barrier effect for HPV vaccination were age (OR 0.680, 95% CI 0.635-0.729, p < 0.001), and immigrant origin (OR 0.215, 95% CI 0.109-0.422, p < 0.001). The variable that showed a facilitating effect for HPV vaccination was HPV PCR (OR 7.402, 95% CI 2.504-21.880, p < 0.001).MDPI AG2023202320232023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion15 p.application/pdfapplication/pdfhttps://hdl.handle.net/2445/204480Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.3390/vaccines11101536Vaccines, 2023, vol. 11, num. 10https://doi.org/10.3390/vaccines11101536cc by (c) Colomé Ceballos, Lara et al, 2023http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2044802026-05-29T05:05:01Z
dc.title.none.fl_str_mv Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
title Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
spellingShingle Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
Colomé Ceballos, Lara
Vacuna del papil·lomavirus
Cribratge
Papillomavirus vaccines
Medical screening
title_short Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
title_full Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
title_fullStr Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
title_full_unstemmed Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
title_sort Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
dc.creator.none.fl_str_mv Colomé Ceballos, Lara
Clua Espuny, Josep Lluís
Ceballos García, Concepción
Clua Queralt, Josep
Pla Farnós, Maria Jesús
Fernández Sáez, José
author Colomé Ceballos, Lara
author_facet Colomé Ceballos, Lara
Clua Espuny, Josep Lluís
Ceballos García, Concepción
Clua Queralt, Josep
Pla Farnós, Maria Jesús
Fernández Sáez, José
author_role author
author2 Clua Espuny, Josep Lluís
Ceballos García, Concepción
Clua Queralt, Josep
Pla Farnós, Maria Jesús
Fernández Sáez, José
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Vacuna del papil·lomavirus
Cribratge
Papillomavirus vaccines
Medical screening
topic Vacuna del papil·lomavirus
Cribratge
Papillomavirus vaccines
Medical screening
description HPV vaccination coverage rates can vary depending on several factors. The main objective of this study is to identify possible independent prognostic factors that have an impact on HPV vaccination in a rural community, specifically related to sexual and reproductive health. A case-control, retrospective, community-based study was carried out on women aged 15 to 40 in the primary health centers of Southern Catalonia's Terres de l'Ebre region, Spain, from 1 January 2020 to 31 December 2022. A random sample of 520 women with an average age of 29.3 (SD 7.8) years old was included in the study. Independent prognostic factors: age OR 0.680 (95% CI: 0.635-0.729, p < 0.001), immigrant origin OR 0.215 (95% CI: 0.109-0.422, p < 0.001), and HPV PCR OR 7.402 (95% CI: 2.504-21.880, p < 0.001). The variables that showed a barrier effect for HPV vaccination were age (OR 0.680, 95% CI 0.635-0.729, p < 0.001), and immigrant origin (OR 0.215, 95% CI 0.109-0.422, p < 0.001). The variable that showed a facilitating effect for HPV vaccination was HPV PCR (OR 7.402, 95% CI 2.504-21.880, p < 0.001).
publishDate 2023
dc.date.none.fl_str_mv 2023
2023
2023
2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/204480
url https://hdl.handle.net/2445/204480
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.3390/vaccines11101536
Vaccines, 2023, vol. 11, num. 10
https://doi.org/10.3390/vaccines11101536
dc.rights.none.fl_str_mv cc by (c) Colomé Ceballos, Lara et al, 2023
http://creativecommons.org/licenses/by/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc by (c) Colomé Ceballos, Lara et al, 2023
http://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 15 p.
application/pdf
application/pdf
dc.publisher.none.fl_str_mv MDPI AG
publisher.none.fl_str_mv MDPI AG
dc.source.none.fl_str_mv Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417412694114304
score 15,811543

Similares en LA Referencia